HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Says 15% Of Inspected Substances Have REACH Registration Problems

Executive Summary

The results of the EU-wide REACH enforcement project are based on inspections of 813 companies in 2019, covering nearly 1,200 substances in total. The European Chemicals Agency previously committed to performing compliance checks on 30% of all REACH-registered substances by 2027.

You may also be interested in...



ECHA Underscores Need For New Funding To Improve Functioning Of REACH, CLP

In its third report on the operation of core chemicals safety management programs, the European Chemicals Agency highlights declining fee income in recent years and proposes a new financing model that would afford greater predictability and support for ongoing priorities.

ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

ECHA Announces Coming Enforcement Projects On REACH Compliance

Industry compliance with REACH registration and authorization requirements will be the subject of coming enforcement projects, according to a recent notice from the European Chemicals Agency. Related investigations have identified violations of late, including unauthorized use of substances of very high concern.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel